» Articles » PMID: 16048958

Establishment of a Superficial Skin Infection Model in Mice by Using Staphylococcus Aureus and Streptococcus Pyogenes

Overview
Specialty Pharmacology
Date 2005 Jul 29
PMID 16048958
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

A new animal model for the purpose of studying superficial infections is presented. In this model an infection is established by disruption of the skin barrier by partial removal of the epidermal layer by tape stripping and subsequent application of the pathogens Staphylococcus aureus and Streptococcus pyogenes. The infection and the infection route are purely topical, in contrast to those used in previously described animal models in mice, such as the skin suture-wound model, where the infection is introduced into the deeper layers of the skin. Thus, the present model is considered more biologically relevant for the study of superficial skin infections in mice and humans. Established topical antibiotic treatments are shown to be effective. The procedures involved in the model are simple, a feature that increases throughput and reproducibility. This new model should be applicable to the evaluation of novel antimicrobial treatments of superficial infections caused by S. aureus and S. pyogenes.

Citing Articles

Mycosynthesis of silver nanoparticles from endophytic and their antibacterial activity against methicillin-resistant and .

Ali E, Rajendran P, Abdallah B Front Microbiol. 2024; 15:1483637.

PMID: 39619697 PMC: 11604631. DOI: 10.3389/fmicb.2024.1483637.


Assessment of airborne bacteria from a public health institution in Mexico City.

Calderon-Ezquerro M, Ponce de Leon A A, Brunner-Mendoza C, Guerrero-Guerra C C, Sanchez-Flores A, Salinas-Peralta I PLOS Glob Public Health. 2024; 4(11):e0003672.

PMID: 39509382 PMC: 11542838. DOI: 10.1371/journal.pgph.0003672.


Restriction of arginine induces antibiotic tolerance in Staphylococcus aureus.

Freiberg J, Reyes Ruiz V, Gimza B, Murdoch C, Green E, Curry J Nat Commun. 2024; 15(1):6734.

PMID: 39112491 PMC: 11306626. DOI: 10.1038/s41467-024-51144-9.


Formulation and Optimization of Solid Lipid Nanoparticle-based Gel for Dermal Delivery of Linezolid using Taguchi Design.

Chauhan I, Singh L Recent Adv Antiinfect Drug Discov. 2024; 19(4):322-347.

PMID: 38243985 DOI: 10.2174/0127724344280309240103062810.


3D-printed wound dressings containing a fosmidomycin-derivative prevent biofilm formation.

van Charante F, Martinez-Perez D, Guarch-Perez C, Courtens C, Sass A, Choinska E iScience. 2023; 26(9):107557.

PMID: 37680458 PMC: 10480667. DOI: 10.1016/j.isci.2023.107557.


References
1.
Gisby J, Bryant J . Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections. Antimicrob Agents Chemother. 2000; 44(2):255-60. PMC: 89667. DOI: 10.1128/AAC.44.2.255-260.2000. View

2.
Goldmann O, Chhatwal G, Medina E . Immune mechanisms underlying host susceptibility to infection with group A streptococci. J Infect Dis. 2003; 187(5):854-61. DOI: 10.1086/368390. View

3.
Alouf J, Muller-Alouf H . Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects. Int J Med Microbiol. 2003; 292(7-8):429-40. DOI: 10.1078/1438-4221-00232. View

4.
Wilcox M, Hall J, Pike H, Templeton P, Fawley W, Parnell P . Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect. 2003; 54(3):196-201. DOI: 10.1016/s0195-6701(03)00147-6. View

5.
Guay D . Treatment of bacterial skin and skin structure infections. Expert Opin Pharmacother. 2003; 4(8):1259-75. DOI: 10.1517/14656566.4.8.1259. View